Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1318 | Clinical Cases–Thyroid/Other | ECE2015

Is thymectomy a solution for myasthenia gravis associated with autoimmune thyroid diseases?

Vasiliu Ioana , Bodescu Ioana , Stefanescu Cipriana , Ciobanu Delia-Gabriela , Ionescu Lidia , Serban Ionela Lacramioara , Vulpoi Carmen

Myasthenia gravis (MG) and autoimmune thyroid diseases (AITD) may coexist and influence one another clinical expression. The opportunity of thymectomy in this association is controversial, since not all the studies have proven its efficacy. We report eight patients (one man and seven women) diagnosed with AITD (Graves’ disease (GD) – five cases, Hashimoto’s thyroiditis (HT) – three cases) and MG. The AITD diagnosis preceded (two cases), followed (three case...

ea0020p168 | Thyroid | ECE2009

Unsual onset of subacute thyroiditis

Stoica Ioana , Plesa Alina , Ciobanu Delia Gabriela , Dinu Roxana , Zbranca Eusebie , Vulpoi Carmen

Subacute thyroiditis (SAT) is a self-limited inflammatory disease of presumed viral etiology, characterized by pain and thriphasic functional thyroid evolution. We report the case of an 54-years-old woman hospitalized in 02.2008 at the Gastroenterology Department for fever, diahreea, significant weight loss (5 kg in one month), with the suspicion of Crohn’s disease (CD). Two weeks before she presented a subfebrile episode with bilateral jugular lymphadenopathy, dysphagia,...

ea0016p795 | Thyroid | ECE2008

Graves’ disease and myasthenia gravis: who comes first?

Vulpoi Carmen , Andriescu Lidia , Ciobanu Delia Gabriela , Ungureanu Maria Christina , Cuciureanu Dan , Grigoras Mihai , Zbranca Eusebie

Graves’ disease (GD) and myasthenia gravis (MG) may be associated and influence one another clinical expression. We report the cases of 3 female patients who presented this particular association. First patient (RL, 55 years), was diagnosed with MG and, 5 years after, developed GD, remitted after 2 years of anti-thyroid drugs (ATD). She is still euthyroid after more than 10 years, and MG is compensated with moderate doses of anticholinesterase drugs (ACD). Thoracic CT sho...

ea0063p648 | Interdisciplinary Endocrinology 1 | ECE2019

Ghrelin expression in breast carcinomas

Armasu Ioana , Ciobanu Delia-Gabriela , Ianole Victor , Vasiliu Ioana , Hristov Ioana , Leustean Letita , Lupascu Cristian , Mocanu Veronica , Serban Ionela Lacramioara , Preda Cristina

Introduction: Breast cancer is, by far, the most frequent cancer among women. Local and systemic factors have been shown to drive growth in breast cancer cells. There is increasing evidence that hormone ghrelin, known for the growth hormone releasing effect and food intake modulator, may also influence cancer growth. Ghrelin has been shown to be produced by some tumor cells, including breast cancer cells.Objective: To analyze ghrelin expression in correl...